BIOMAT Database Logo BIOMAT Database Logo

Visual compatibility of enalaprilat with selected intravenous medications during simulated Y-site injection. 1990

D F Thompson, and L V Allen, and M L Stiles
Drug Information Service, Oklahoma City, OK 73190.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D004344 Drug Incompatibility The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed) Drug Incompatibilities,Incompatibilities, Drug,Incompatibility, Drug
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D015773 Enalaprilat The active metabolite of ENALAPRIL and one of the potent, intravenously administered, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion. Enalaprilic Acid,1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate,Enalaprilat Anhydrous,Enalaprilat Citrate, Anhydrous,Enalaprilat Dihydrate,Enalaprilat, (R)-Isomer, Anhydrous,MK-422,Pres iv,Vasotec,Xanef,MK 422,MK422

Related Publications

D F Thompson, and L V Allen, and M L Stiles
Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection.
June 1989, International journal of clinical pharmacology, therapy, and toxicology,
D F Thompson, and L V Allen, and M L Stiles
Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
November 1990, American journal of hospital pharmacy,
D F Thompson, and L V Allen, and M L Stiles
Visual compatibility of tolazoline hydrochloride with various medications during simulated Y-site injection.
August 1990, American journal of hospital pharmacy,
D F Thompson, and L V Allen, and M L Stiles
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
March 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
D F Thompson, and L V Allen, and M L Stiles
Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection.
March 1994, American journal of hospital pharmacy,
D F Thompson, and L V Allen, and M L Stiles
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
May 1991, American journal of hospital pharmacy,
D F Thompson, and L V Allen, and M L Stiles
Visual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injection.
November 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
D F Thompson, and L V Allen, and M L Stiles
Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
October 1991, American journal of hospital pharmacy,
D F Thompson, and L V Allen, and M L Stiles
Visual compatibility of gallium nitrate with selected drugs during simulated Y-site injection.
June 1993, American journal of hospital pharmacy,
D F Thompson, and L V Allen, and M L Stiles
Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection.
July 1988, American journal of hospital pharmacy,
Copied contents to your clipboard!